A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients

Summary

This is a multicentre, open-label, one-arm Phase II extension study to evaluate the safety and tolerability of MIV-711 in patients with knee joint osteoarthritis (OA).

Timeline

Start

2016-09

Primary completion

2017-11-28

Completion

2017-11-28

Outcome

Met primary endpoint

release “today announced positive top-line results from the MIV-711 phase IIa extension study (MIV-711-202). The study met the primary endpoint” medivir.com ↗

Drugs

Indications